Nyxoah S.A. Stock Analysis & AI Score
Nyxoah S.A. (NYXH) has an ST Score of 33.6 (C-), driven by its Forecast (A) and held back by its Momentum (D-). Analysts rate it Buy with a $4.08 price target (+221.3% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Specialties |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Nyxoah S.A. (NYXH) has an ST Score of 33.6 (C-), driven by its Forecast (A) and held back by its Momentum (D-). Analysts rate it Buy with a $4.08 price target (+221.3% upside).
- Strongest
- ForecastA
- Weakest
- MomentumD-
All factor grades
- ForecastA
- GrowthB-
- ValuationC
- Financial StrengthD
- ProfitabilityD-
- MomentumD-
- Piotroski2/9
Contact
NYXH stock: frequently asked questions
What is NYXH's ST Score?
Nyxoah S.A. (NYXH) has an ST Score of 33.6 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is NYXH a buy, hold, or sell?
Analysts rate NYXH a Buy, with a price target of $4.08 (+221.3% vs the current price). Our ST Score grades it C- (33.6/100). The ST Score is a data-driven signal, not a recommendation.
What are NYXH's factor grades?
Valuation C, Profitability D-, Financial Strength D, Momentum D-, Growth B-, Forecast A.
What is NYXH's valuation grade?
Nyxoah S.A. (NYXH) earns a valuation grade of C, measured against Medical - Specialties peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is NYXH's growth grade?
Nyxoah S.A. (NYXH) earns a growth grade of B-, measured against Medical - Specialties peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is NYXH's profitability grade?
Nyxoah S.A. (NYXH) earns a profitability grade of D-, measured against Medical - Specialties peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is NYXH's financial strength grade?
Nyxoah S.A. (NYXH) earns a financial strength grade of D, measured against Medical - Specialties peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for NYXH?
The average analyst price target for Nyxoah S.A. (NYXH) is $4.08 from 5 analysts, which is +221.3% versus the recent price of $1.27.
What is NYXH's Piotroski score?
Nyxoah S.A. (NYXH) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.